The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Oral Contraceptives and Risk of Ovarian Cancer and Breast Cancer Among High-Risk Women: A Systematic Review and Meta-Analysis
Open accessAbstract
Purpose: To estimate the risks of ovarian cancer and breast cancer associated with oral contraceptive (OC) use among women at elevated risk owing to mutations in BRCA1/2 or a strong family history. Methods: We searched PubMed, Embase, the Cochrane Database of Systematic Reviews, and ClinicalTrials.gov for studies published 2000 to 2012 that evaluated associations between OC use and breast or ovarian cancer among women who are carriers of a BRCA1/2 mutation or have a family history of breast or ovarian cancer. Results: From 6,476 unique citations, we identified six studies examining ovarian cancer risk in BRCA1/2 mutation carriers and eight studies examining breast cancer risk in BRCA1/2 mutation carriers. For BRCA1/2 mutation carriers combined, meta-analysis showed an inverse association between OC use and ovarian cancer (odds ratio [OR], 0.58; 95% CI, 0.46 to 0.73) and a nonstatistically significant association with breast cancer (OR, 1.21; 95% CI, 0.93 to 1.58). Findings were similar when examining BRCA1 and BRCA2 mutation carriers separately. Data were inadequate to perform meta-analyses examining duration or timing of use. For women with a family history of ovarian or breast cancer, we identified four studies examining risk for ovarian cancer and three for breast cancer, but differences between studies precluded combining the data for meta-analyses, and no overall pattern could be discerned. Conclusion: Our analyses suggest that associations between ever use of OCs and ovarian and breast cancer among women who are BRCA1 or BRCA2 mutation carriers are similar to those reported for the general population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Siegel, R., Naishadham, D., & Jemal, A. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20138 · Cited by 10,679
Antoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, Å., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375033 · Cited by 3,680
Cannistra, S. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra041842 · Cited by 2,129
Buys, S. S. (2011) · JAMA · doi:10.1001/jama.2011.766 · Cited by 1,323
Rebbeck, T. R., Kauff, N. D., & Domchek, S. M. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn442 · Cited by 939
Collaborative Group on Epidemiological Studies of Ovarian Cancer (2008) · The Lancet · doi:10.1016/s0140-6736(08)60167-1 · Cited by 822
Atsma, F., Bartelink, M.-L. E. L., Grobbee, D. E., & van der Schouw, Y. T. (2006) · Menopause · doi:10.1097/01.gme.0000218683.97338.ea · Cited by 744
Mavaddat, N., Barrowdale, D., Andrulis, I. L., Domchek, S. M., Eccles, D., Nevanlinna, H., Ramus, S. J., Spurdle, A., Robson, M., Sherman, M., et al. (2012) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0775 · Cited by 669
Oral Contraceptives and the Risk of Hereditary Ovarian Cancer
Narod, S. A., Risch, H., Moslehi, R., Dørum, A., Neuhausen, S., Olsson, H., Provencher, D., Radice, P., Evans, G., Bishop, S., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808133390702 · Cited by 615
Atchley, D. P., Albarracin, C. T., Lopez, A., Valero, V., Amos, C. I., Gonzalez-Angulo, A. M., Hortobagyi, G. N., & Arun, B. K. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.6231 · Cited by 604
Stratton, M. R. (1997) · The Lancet · doi:10.1016/s0140-6736(96)10109-4 · Cited by 579
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions
Antoniou, A. C., Cunningham, A. P., Peto, J., Evans, D. G., Lalloo, F., Narod, S. A., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Southey, M. C., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604305 · Cited by 525
Modan, B., Hartge, P., Hirsh-Yechezkel, G., Chetrit, A., Lubin, F., Beller, U., Ben-Baruch, G., Fishman, A., Menczer, J., Struewing, J. P., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107263450401 · Cited by 385
Oral Contraceptives and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers
Narod, S. A. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.23.1773 · Cited by 380
Gierisch, J. M., Coeytaux, R. R., Urrutia, R. P., Havrilesky, L. J., Moorman, P. G., Lowery, W. J., Dinan, M., McBroom, A. J., Hasselblad, V., Sanders, G. D., et al. (2013) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0298 · Cited by 372
Self-citationEpidemiology of Ovarian Cancer
Permuth-Wey, J., & Sellers, T. A. (2009) · Methods in Molecular Biology · doi:10.1007/978-1-60327-492-0_20 · Cited by 326
McLaughlin, J. R., Risch, H. A., Lubinski, J., Moller, P., Ghadirian, P., Lynch, H., Karlan, B., Fishman, D., Rosen, B., Neuhausen, S. L., et al. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70983-4 · Cited by 247
Risk of Breast Cancer With Oral Contraceptive Use in Women With a Family History of Breast Cancer
Grabrick, D. M. (2000) · JAMA · doi:10.1001/jama.284.14.1791 · Cited by 218
Urrutia, R. P., Coeytaux, R. R., McBroom, A. J., Gierisch, J. M., Havrilesky, L. J., Moorman, P. G., Lowery, W. J., Dinan, M. A., Hasselblad, V., Sanders, G. D., et al. (2013) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3182994c43 · Cited by 165
Self-citationAntoniou, A. C., Rookus, M. A., Andrieu, N., Brohet, R. M., Chang-Claude, J. C., Peock, S., Cook, M., Evans, D. G., Eeles, R. A., EMBRACE, et al. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0546 · Cited by 157
Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations
Whittemore, A. S., Balise, R. R., Pharoah, P. D. P., DiCioccio, R. A., Oakley-Girvan, I. A., Ramus, S. J., Daly, M. B., Usinowicz, M. B., Garlinghouse-Jones, K., Ponder, B. A. J., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602239 · Cited by 152
Brohet, R. M., Goldgar, D. E., Easton, D. F., Antoniou, A. C., Andrieu, N., Chang-Claude, J. C., Peock, S., Eeles, R. A., Cook, M., Chu, C., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.1179 · Cited by 151
Milne, R. L., Knight, J. A., John, E. M., Dite, G. S., Balbuena, R., Ziogas, A., Andrulis, I. L., West, D. W., Li, F. P., Southey, M. C., et al. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0376 · Cited by 135
BRCA1 and BRCA2 Mutation Carriers, Oral Contraceptive Use, and Breast Cancer Before Age 50
Haile, R. W., Thomas, D. C., McGuire, V. M., Felberg, A., John, E. M., Milne, R. L., Hopper, J. L., Jenkins, M. A., Levine, A. J., Daly, M. M., et al. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0258 · Cited by 123
Grann, V. R., Patel, P. R., Jacobson, J. S., Warner, E., Heitjan, D. F., Ashby‐Thompson, M., Hershman, D. L., & Neugut, A. I. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1043-4 · Cited by 123
Gillanders, W. E., & Simon, P. O. (2005) · The Women s Oncology Review · doi:10.1080/14733400500235731 · Cited by 123
Long‐term effects of oral contraceptives on ovarian cancer risk
Bosetti, C., Negri, E., Trichopoulos, D., Franceschi, S., Beral, V., Τζώνου, Α., Parazzini, F., Greggi, S., & Vecchia, C. L. (2002) · International Journal of Cancer · doi:10.1002/ijc.10696 · Cited by 119
Gronwald, J., Byrski, T., Huzarski, T., Cybulski, C., Sun, P., Tulman, A., Narod, S. A., & Lubiński, J. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-9051-5 · Cited by 99
Online Tool to Guide Decisions forBRCA1/2Mutation Carriers
Kurian, A. W., Muñoz, D. F., Rust, P., Schackmann, E. A., Smith, M. H., Clarke, L. D., Mills, M. A., & Plevritis, S. K. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.6060 · Cited by 97
Lee, E., Ma, H., McKean‐Cowdin, R., Berg, D. V. D., Bernstein, L., Henderson, B. E., & Ursin, G. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0396 · Cited by 97
Silvera, S. A. N., Miller, A. B., & Rohan, T. E. (2005) · Cancer Causes & Control · doi:10.1007/s10552-005-0343-1 · Cited by 75
Should the ovaries be removed or retained at the time of hysterectomy for benign disease?
Hickey, M., Ambekar, M., & Hammond, I. G. (2009) · Human Reproduction Update · doi:10.1093/humupd/dmp037 · Cited by 69
Family history of cancer, oral contraceptive use, and ovarian cancer risk
Walker, G. R., Schlesselman, J. J., & Ness, R. B. (2002) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2002.118657 · Cited by 66
Oral contraceptives and risk of familial breast cancer
Heimdal, K., Skovlund, E., & Møller, P. (2002) · Cancer Detection and Prevention · doi:10.1016/s0361-090x(02)00004-1 · Cited by 58
Bernholtz, S., Laitman, Y., Kaufman, B., Paluch–Shimon, S., & Friedman, E. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1509-z · Cited by 37
Figueiredo, J. C., Haile, R. W., Bernstein, L., Malone, K. E., Largent, J. A., Langholz, B. M., Lynch, C. F., Bertelsen, L., Capanu, M., CONCANNON, P. J., et al. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0455-5 · Cited by 35
Cited by
Ovarian cancer statistics, 2018
Torre, L. A., Trabert, B., DeSantis, C. E., Miller, K. D., Samimi, G., Runowicz, C. D., Gaudet, M. M., Jemal, A., & Siegel, R. L. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21456 · Cited by 3,492
Matulonis, U. A., Sood, A. K., Fallowfield, L., Howitt, B. E., Sehouli, J., & Karlan, B. Y. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.61 · Cited by 1,362
Daly, M. B., Pal, T., Berry, M. P., Buys, S. S., Dickson, P., Domchek, S. M., Elkhanany, A., Friedman, S., Goggins, M., Hutton, M. L., et al. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2021.0001 · Cited by 1,112
Genetics of breast cancer: a topic in evolution
Shiovitz, S., & Korde, L. A. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv022 · Cited by 525
Ovarian Cancer Prevention and Screening
Menon, U., Karpinskyj, C., & Gentry-Maharaj, A. (2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002580 · Cited by 279
Metadata
- Authors
- Moorman, P. G., Havrilesky, L. J., Gierisch, J. M., Coeytaux, R. R., Lowery, W. J., Peragallo Urrutia, R., Dinan, M., McBroom, A. J., Hasselblad, V., Sanders, G. D., & Myers, E. R.
- Venue
- Journal of Clinical Oncology
- Published
- 2013-11-20
- Volume
- 31
- Issue
- 33
- Pages
- 4188-4198
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2166187750
- Cited by
- 303
- References
- 38
- FWCI
- 2.18
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.